Stock Markets August 20, 2026 09:05 AM

Fluence Energy Slips as Guidance Reset and Manufacturing Delays Weigh on Sentiment

Shares fall in pre-market trade after company trims FY26 revenue and lowers adjusted EBITDA outlook amid production issues at new contract manufacturers

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
FLNC

Fluence Energy shares fell in pre-market trading as investors continue to react to a sizable guidance reduction announced with fiscal third-quarter results, including a revenue cut and a swing to negative adjusted EBITDA driven by roughly $400 million of project deliveries pushed into fiscal 2027 due to production problems at new contract manufacturing sites.

Fluence Energy Slips as Guidance Reset and Manufacturing Delays Weigh on Sentiment
FLNC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Fluence cut FY26 revenue guidance to $2.9 billion - $3.1 billion from $3.2 billion - $3.6 billion; the revised range missed the ~ $3.35 billion Street consensus.
  • Management cited about $400 million of project deliveries pushed into fiscal 2027 because of production problems at new contract manufacturing sites domestically and internationally.
  • Adjusted EBITDA guidance swung from an expected profit of around $50 million to a loss of about $10 million at the midpoint, a roughly $60 million change in earnings expectations.

Fluence Energy shares opened weaker in pre-market trade, slipping 2.7% to $11.74 as the market continues to process a significant reset in the company's fiscal-year expectations. The move follows the firm's fiscal third-quarter report on August 5, 2026, when management reduced its full-year FY26 revenue outlook to a range of $2.9 billion to $3.1 billion, down from a prior projection of $3.2 billion to $3.6 billion. That revised revenue range also came in below the Wall Street consensus of about $3.35 billion.

Company executives said the shortfall stems primarily from roughly $400 million in project deliveries being deferred into fiscal 2027. Management pointed to production problems at new contract manufacturing sites, both in the United States and abroad, as the proximate cause of the delays.

Alongside the revenue reduction, Fluence materially altered its adjusted EBITDA outlook. The company moved from guidance that targeted an adjusted EBITDA profit of around $50 million to a midpoint that implies an adjusted EBITDA loss of approximately $10 million. That represents an earnings swing in the neighborhood of $60 million versus prior expectations.

Analysts reacted quickly after the results. Morgan Stanley lowered its price target to $15 from $16, while Roth Capital took a larger step, cutting its target to $18 from $26 the day after the earnings release. Despite these moves, the consensus rating across more than 20 analysts remains a "Hold," signaling limited conviction among the analyst community even as the stock is trading well below the average 12-month price target.

Today's pre-market weakness is occurring against a generally soft tone in U.S. equity markets. The S&P 500 is down 0.5%, the Dow Jones is lower by 0.8%, and the NASDAQ has declined 0.7%. In this environment, high-beta, unprofitable growth names in the clean energy sector tend to underperform, and Fluence fits that profile: the company carries a negative EPS and negative free cash flow.

From a trading-range perspective, the shares have pulled back substantially from a 52-week high of $33.51 but remain above the 52-week low of $6.60. That spread highlights the stock's volatility and the sensitivity of investor sentiment to operational and guidance developments.

Taken together, the guidance cut, the deferred $400 million of project deliveries, and the wave of analyst price-target reductions have created a persistent overhang on Fluence's shares. Until the company can demonstrate that the manufacturing ramp-up issues are resolved and that the delayed project deliveries are firmly on track for fiscal 2027, investor sentiment is likely to remain cautious.


Clear summary

Fluence Energy's stock is trading lower in pre-market activity following an earnings-driven guidance reset that reduced FY26 revenue guidance and shifted adjusted EBITDA guidance from a modest profit to a small loss, driven by around $400 million in projects delayed into fiscal 2027 due to production problems at new contract manufacturing sites.

Market context and outlook

  • Analyst revisions followed the announcement, with Morgan Stanley and Roth Capital lowering price targets the day after the earnings release.
  • Broader weakness in U.S. markets is amplifying selling pressure on high-beta, unprofitable clean energy growth names like Fluence.

Risks

  • Operational risk: Production problems at new contract manufacturing sites are delaying project deliveries, affecting revenue timing and near-term results - impacts the clean energy and manufacturing supply chain sectors.
  • Analyst and sentiment risk: Multiple price-target reductions and a consensus "Hold" rating among more than 20 analysts could maintain selling pressure until visibility improves - impacts investor demand for high-beta growth stocks.
  • Market risk: Broad weakness in U.S. equity indices amplifies moves in unprofitable, high-beta clean energy names, potentially leading to outsized share-price volatility.

More from Stock Markets

Athens market edges up as banking, construction and travel lifts broader index Aug 20, 2026 Tactical Resources Sees U.S. Market as Strategic Priority as Nasdaq Listing Begins Aug 20, 2026 Marathon Digital Jumps After Long Ridge Deal; AI Data Center Strength Lifts Sentiment Aug 20, 2026 China's July semiconductor equipment imports rebound with 9% year-on-year rise, Barclays says Aug 20, 2026 Private Equity Eyes Distressed SaaS Stocks — Are Real Bargains Left? Aug 20, 2026